Advertisement
Advertisement

SGMT

SGMT logo

Sagimet Biosciences Inc. Series A Common Stock

5.66
USD
Sponsored
+0.30
+5.63%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

5.67

0.00
+0.05%

SGMT Earnings Reports

Positive Surprise Ratio

SGMT beat 6 of 10 last estimates.

60%

Next Report

Date of Next Report
Mar 12, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.43
Implied change from Q3 25 (Revenue/ EPS)
--
/
+7.50%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-14.00%

Sagimet Biosciences Inc. Series A Common Stock earnings per share and revenue

On Nov 13, 2025, SGMT reported earnings of -0.40 USD per share (EPS) for Q3 25, missing the estimate of -0.39 USD, resulting in a -1.70% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -12.24% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of -0.43 USD, with revenue projected to reach -- USD, implying an increase of 7.50% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Sagimet Biosciences Inc. Series A Common Stock reported EPS of -$0.40, missing estimates by -1.7%, and revenue of $0.00, 0% as expectations.
The stock price moved down -12.24%, changed from $8.82 before the earnings release to $7.74 the day after.
The next earning report is scheduled for Mar 12, 2026.
Based on 12 analysts, Sagimet Biosciences Inc. Series A Common Stock is expected to report EPS of -$0.43 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement